µå·¯±×ÀÎÆ÷¸ÞÀÎ
 

»óº´Äڵ忡 µû¸¥ »óº´¸íÀ» È®ÀÎ ÇϽǼö ÀÖ½À´Ï´Ù.  
»óº´ÄÚµå ÇÑ±Û»óº´¸í ¿µ¹®»óº´¸í
G73 ´Þ¸® ºÐ·ùµÈ Áúȯ¿¡¼­ÀÇ ±ÙÀ°½Å°æÀÌÇàºÎ ¹× ±ÙÀ°ÀÇ Àå¾Ö Disorders of myoneural junction and muscle in diseases classified elsewhere
G730 ³»ºÐºñ¼º Áúȯ¿¡¼­ÀÇ ±Ù¹«·ÂÁõÈıº Myasthenic syndromes in endocrine diseases
G730 ´ç´¢º´¼º ±ÙÀ§Ãà¿¡¼­ÀÇ ±Ù¹«·ÂÁõÈıº (4´ÜÀ§ ¼ýÀÚ .4¿¡ ÇØ´çµÇ´Â E10-E14+) Myasthenic syndromes in diabetic amyotrophy(E10-E14+ ¿¡¼­ .4)
G730 °©»ó¼±µ¶Áõ[°©»ó¼±±â´ÉÇ×ÁøÁõ]¿¡¼­ÀÇ ±Ù¹«·ÂÁõÈıº Myasthenic syndromes in thyrotoxicosis[hyperthyroidism](E05.-+)
G731 ÀÌÆ°-¶÷º£¸£Æ® ÁõÈıº Eaton-Lambert syndrome(C00-D48+)
G732 ½Å»ý¹°Áúȯ¿¡¼­ÀÇ ±âŸ ±Ù¹«·ÂÁõÈıº Other myasthenic syndromes in neoplastic disease (C00-D48+)
G733 ´Þ¸® ºÐ·ùµÈ ±âŸ Áúȯ¿¡¼­ÀÇ ±Ù¹«·ÂÁõÈıº Myasthenic syndromes in other diseases classified elsewhere
G734 ´Þ¸® ºÐ·ùµÈ °¨¿°¼º ¹× ±â»ýÃæ¼º Áúȯ¿¡¼­ÀÇ ±Ùº´Áõ Myopathy in infectious and parasitic diseases classified elsewhere
G735 ³»ºÐºñ¼º Áúȯ¿¡¼­ÀÇ ±Ùº´Áõ Myopathy in endocrine diseases
G735 ºÎ°©»ó±â´ÉÇ×ÁøÁõ¿¡¼­ÀÇ ±Ùº´Áõ Myopathy in hyperparathyrodism(E21.0-E213+)
G735 ºÎ°©»ó¼±±â´ÉÀúÇÏÁõ¿¡¼­ÀÇ ±Ùº´Áõ Myopathy in hypoparathyroidism(E20.-+)
G735 °©»ó¼±µ¶¼º ±Ùº´Áõ Thyrotoxic myopathy (E05.-+)
G736 ´ë»çÁúȯ¿¡¼­ÀÇ ±Ùº´Áõ Myopathy in metabolic diseases
G736 ±Û¸®ÄÚÁ¨ÃàÀûº´¿¡¼­ÀÇ ±Ùº´Áõ Myopathy in glycogen storage disease(E74.0+)
G736 ÁöÁúÃàÀûÀå¾Ö¿¡¼­ÀÇ ±Ùº´Áõ Myopathy in lipid storage disorders(E75.-+)
G737 ´Þ¸® ºÐ·ùµÈ ±âŸ Áúȯ¿¡¼­ÀÇ ±Ùº´Áõ Myopathy in other diseases classified elsewhere
G737 ·ù¸¶Æ¼½º°üÀý¿°¿¡¼­ÀÇ ±Ùº´Áõ Myopathy in rheumatoid arthritis(M05-M06+)
G737 ÇǺΰæÈ­Áõ¿¡¼­ÀÇ ±Ùº´Áõ Myopathy in scleroderma (M34.8+)
G737 °ÇÁ¶ÁõÈıº[½¦±×·»]¿¡¼­ÀÇ ±Ùº´Áõ Myopathy in sicca syndrome[Sjogren](M35.0+)
G737 Àü½Å¼º È«¹Ý·çǪ½º¿¡¼­ÀÇ ±Ùº´Áõ Myopathy in systemic lupus erythematosus(M32.1+)
441  442  443  444  445  [446] 447  448  449  450